Online citations, reference lists, and bibliographies.
← Back to Search

Chitosan: A Promising Therapeutic Agent And Effective Drug Delivery System In Managing Diabetes Mellitus.

S. Sarkar, D. Das, Prachurjya Dutta, Jatin Kalita, S. B. Wann, P. Manna
Published 2020 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Chitosan, a promising carbohydrate biopolymer is gaining scientific attention in a wide range of biomedical applications due to its outstanding chemical and pharmacokinetic properties. Recently, various studies have demonstrated the beneficial activities of chitosan in protecting and proliferating pancreatic beta cells, lowering hyperglycemia, and preventing impaired lipid metabolism associated diabetes mellitus. Moreover, chitosan has also been used in formulating several types of micro/nano-carriers for the delivery of different antidiabetic drugs, like insulin, GLP1, exendin-4, DPP-4 inhibitor, and plasmid encoding insulin or GLP to reduce hyperglycemia. This review for the first time provides an overview of the currently available evidences on the potential benefits of chitosan in managing diabetes mellitus and also emphasizes on the chitosan-based micro/nano-carriers in delivery of various antidiabetic drugs via oral, nasal, and subcutaneous routes. The outcome of this review will be helpful for the development of a novel therapeutic to achieve better control of diabetes mellitus.
This paper references
10.1007/s42000-018-0014-8
Diabetes and lipid metabolism
V. Athyros (2018)
10.1016/j.jconrel.2013.05.031
Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan.
Sukyung Ahn (2013)
10.1080/02652048.2019.1604846
Self-assembly pH-sensitive chitosan/alginate coated polyelectrolyte complexes for oral delivery of insulin
T. Chen (2019)
10.1016/j.biomaterials.2010.05.042
Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection.
K. Sonaje (2010)
10.1039/c7nr01677h
A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
K. Jiang (2017)
10.1016/J.JDDST.2016.10.010
Nanoencapsulated chitosan nanoparticles in emulsion-based oral delivery system: In vitro and in vivo evaluation of insulin loaded formulation
Gülşah Erel (2016)
10.1210/jc.2011-0246
Preservation of β-cell function: the key to diabetes prevention.
R. DeFronzo (2011)
10.1038/srep38146
Corrigendum: Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy
C. Murugan (2016)
10.1007/s10924-016-0865-5
Chitin and Chitosan: Structure, Properties and Applications in Biomedical Engineering
S. M. A. Islam (2016)
10.3390/md16080251
Functional Comparison of High and Low Molecular Weight Chitosan on Lipid Metabolism and Signals in High-Fat Diet-Fed Rats
S. Liu (2018)
10.1021/bm800276d
Why is chitosan mucoadhesive?
Ioannis A Sogias (2008)
10.1007/s11095-007-9367-4
Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
B. Sarmento (2007)
10.1038/s41387-019-0099-4
Chitosan oligosaccharide (GO2KA1) improves postprandial glycemic response in subjects with impaired glucose tolerance and impaired fasting glucose and in healthy subjects: a crossover, randomized controlled trial
S. Jeong (2019)
10.1371/journal.pone.0101461
Transdermal Delivery of Insulin by Amidated Pectin Hydrogel Matrix Patch in Streptozotocin-Induced Diabetic Rats: Effects on Some Selected Metabolic Parameters
S. I. Hadebe (2014)
10.1016/J.BBRC.2006.10.124
AMP-activated protein kinase regulates PEPCK gene expression by direct phosphorylation of a novel zinc finger transcription factor.
E. Inoue (2006)
10.1023/A:1016444808000
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells
N. G. Schipper (2004)
10.1016/j.actbio.2015.10.017
Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
G. Wang (2016)
10.1016/j.ddtec.2005.05.008
Chitosan and the mucosal delivery of biotechnology drugs.
Mohamed M. Issa (2005)
10.1016/J.BIOMATERIALS.2004.06.020
Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption.
J. Smith (2005)
10.1016/j.ijbiomac.2019.07.168
Cellular uptake and transport characteristics of chitosan modified nanoparticles in Caco-2 cell monolayers.
T. Dou (2019)
10.2337/dc13-1518
Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
W. Garvey (2014)
10.1016/J.BBRC.2005.10.007
Adiponectin represses gluconeogenesis independent of insulin in hepatocytes.
H. Zhou (2005)
10.1016/S0168-3659(97)00154-5
Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
A. Kotzé (1998)
10.1016/j.biomaterials.2015.07.045
Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: A controlled dual protein-drug delivery system.
N. Shrestha (2015)
10.1023/B:PHAM.0000016248.30579.2f
Biodegradable Triblock Copolymer Microspheres Based on Thermosensitive Sol-Gel Transition
Y. M. Kwon (2004)
10.1016/J.JCONREL.2004.08.010
Recent advances on chitosan-based micro- and nanoparticles in drug delivery.
S. Agnihotri (2004)
10.1248/BPB.33.1511
Antidiabetic effect and mechanism of chitooligosaccharides.
C. Ju (2010)
10.3109/10717544.2014.932861
In vitro and in vivo evaluation of thermosensitive chitosan hydrogel for sustained release of insulin
Farzaneh Ghasemi Tahrir (2016)
10.1002/JAT.741
Toxicological, medical and industrial hygiene aspects of glutaraldehyde with particular reference to its biocidal use in cold sterilization procedures
B. Ballantyne (2001)
10.1016/J.CARBPOL.2010.04.068
Effects of interpenetration of thermo-sensitive gels by crosslinking of chitosan on nasal delivery of insulin: In vitro characterization and in vivo study
T. W. Chung (2010)
10.1016/S1773-2247(04)50081-3
A study of insulin-chitosan complex nanoparticles used for oral administration
F. Cui (2004)
10.1271/bbb.64.965
Effect of Dietary Chitosans with Different Viscosity on Plasma Lipids and Lipid Peroxidation in Rats Fed on A Diet Enriched with Cholesterol
M. Chiang (2000)
10.1016/j.ijpharm.2019.03.020
Cp1-11 peptide/insulin complex loaded pH-responsive nanoparticles with enhanced oral bioactivity.
Xingyu Chen (2019)
10.1038/mt.2010.143
Intracellular trafficking and decondensation kinetics of chitosan-pDNA polyplexes.
M. Thibault (2010)
10.1021/JS970124I
Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin.
C. Damgé (1997)
10.1016/J.ADDR.2007.08.019
Current challenges in non-invasive insulin delivery systems: a comparative review.
E. Khafagy (2007)
10.1080/02652040400015403
Nasal delivery of insulin using chitosan microspheres
J. Varshosaz (2004)
10.1023/A:1012160102740
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement
N. G. Schipper (2004)
10.3390/md14050099
“The Good, the Bad and the Ugly” of Chitosans
B. Bellich (2016)
10.3390/pharmaceutics9040053
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery
M. Mohammed (2017)
10.1016/S0168-3659(03)00126-3
Chitosan-based gastrointestinal delivery systems.
Radi Hejazi (2003)
10.1038/gt.2011.25
Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of type 2 diabetes
M. Jean (2011)
10.1093/JN/119.8.1100
Interaction of bile acids, phospholipids, cholesterol and triglyceride with dietary fibers in the small intestine of rats.
K. Ebihara (1989)
10.1021/BM0607776
Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
Yu-Hsin Lin (2007)
10.1186/1472-6882-14-272
Effect of long-term supplementation of low molecular weight chitosan oligosaccharide (GO2KA1) on fasting blood glucose and HbA1c in db/db mice model and elucidation of mechanism of action
Jong-Gwan Kim (2014)
10.1021/bm900097s
New insights into chitosan-DNA interactions using isothermal titration microcalorimetry.
P. Ma (2009)
10.1023/A:1016418523014
Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles
A. Dyer (2004)
10.3390/molecules23102661
Chitosan-Based Nanomaterials for Drug Delivery
Jianghua Li (2018)
10.1271/BBB.59.1211
Continuous and massive intake of chitosan affects mineral and fat-soluble vitamin status in rats fed on a high-fat diet.
K. Deuchi (1995)
10.1016/j.jconrel.2012.07.035
Chitosan-zinc-insulin complex incorporated thermosensitive polymer for controlled delivery of basal insulin in vivo.
M. Oak (2012)
10.1016/j.jconrel.2018.03.013
N‐trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N‐trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer
Guanyu Chen (2018)
10.1002/adtp.201800136
Chitooligosaccharide Biguanide Repairs Islet β‐Cell Dysfunction by Activating the IRS‐2/PI3K/Akt Signaling Pathway in Type 2 Diabetic Rats
Yalu Zou (2019)
10.1016/j.msec.2012.09.001
Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model.
Piyasi Mukhopadhyay (2013)
10.1007/S10068-010-0178-8
Antidiabetic activity of nanopowdered chitosan in db/db mice
M. H. Seo (2010)
10.2337/diab.45.3.S27
Diabetic Dyslipidemia: Basic Mechanisms Underlying the Common Hypertriglyceridemia and Low HDL Cholesterol Levels
H. Ginsberg (1996)
10.1080/10717540500309040
Nasal Delivery of Insulin Using Bioadhesive Chitosan Gels
J. Varshosaz (2006)
10.1038/nrd4477
Managing diabetes with nanomedicine: challenges and opportunities
O. Veiseh (2015)
10.1210/EN.2003-0288
Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors.
C. Lee (2003)
10.1080/10408690390826473
Production, Properties, and Some New Applications of Chitin and Its Derivatives
J. Synowiecki (2003)
10.1016/j.biomaterials.2017.03.028
Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin.
Zhiyu He (2017)
10.1016/S0378-5173(97)00287-1
Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: in vitro evaluation in Caco-2 cell monolayers
A. Kotzé (1997)
10.1211/0022357011776441
Chitosan: some pharmaceutical and biological aspects ‐ an update
A. K. Singla (2001)
10.1039/c8bm01485j
Enhanced oral absorption of insulin using colon-specific nanoparticles co-modified with amphiphilic chitosan derivatives and cell-penetrating peptides.
F. Guo (2019)
10.1016/S0928-0987(01)00172-5
Chitosan and its derivatives in mucosal drug and vaccine delivery.
I. M. van der Lubben (2001)
10.1111/j.1745-7254.2008.00888.x
Expression of human insulin gene wrapped with chitosan nanoparticles in NIH3T3 cells and diabetic rats
Li Niu (2008)
10.2174/1566524053766086
Type 2 diabetes as a lipid disorder.
M. Taskinen (2005)
10.2147/IJN.S96146
Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation
Liyao Liu (2016)
10.1016/j.ijbiomac.2017.12.078
A review on chitosan and its nanocomposites in drug delivery.
A. Ali (2018)
10.1016/J.EJPB.2006.09.005
Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
B. Sarmento (2007)
10.4155/TDE.12.120
Towards the nasal delivery of insulin.
H. Nazar (2012)
10.1021/acs.biomac.8b00863
Complex Coacervates between a Lactose-Modified Chitosan and Hyaluronic Acid as Radical-Scavenging Drug Carriers.
Federica Vecchies (2018)
10.3748/wjg.v22.i4.1433
Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.
M. Márquez (2016)
10.1111/j.1749-6632.2012.06468.x
Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering
Daniel F. Berenson (2011)
10.2174/187221109787158346
Chitosan and its use in design of insulin delivery system.
T. Wong (2009)
10.3109/10717541003762888
Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride
L. D. du Plessis (2010)
10.2174/1389201033489748
Application of chitin and chitosan derivatives in the pharmaceutical field.
Y. Kato (2003)
10.1016/S0928-0987(99)00032-9
Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
N. G. Schipper (1999)
10.1016/j.heliyon.2019.e01684
Degradability of chitosan micro/nanoparticles for pulmonary drug delivery
N. Islam (2019)
10.1016/j.jfda.2016.11.015
The regulatory effects of fish oil and chitosan on hepatic lipogenic signals in high-fat diet-induced obese rats.
C. Chiu (2017)
10.1016/j.actbio.2018.04.020
Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer.
H. Yang (2018)
10.1016/S0021-9150(01)00659-1
The effect of chronic insulin delivery via the intraperitoneal versus the subcutaneous route on hepatic triglyceride secretion rate in streptozotocin diabetic rats.
T. M. Mason (2002)
10.1023/A:1018967116988
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
P. Artursson (2004)
10.1021/jf100662r
Chitosan reduces gluconeogenesis and increases glucose uptake in skeletal muscle in streptozotocin-induced diabetic rats.
S. Liu (2010)
10.1016/J.IJPHARM.2003.12.026
Chitosan microspheres as a potential carrier for drugs.
V. Sinha (2004)
10.1111/j.1742-1241.2009.02276.x
New ways of insulin delivery
L. Heinemann (2010)
10.1248/BPB.26.1100
Antidiabetic effects of chitosan oligosaccharides in neonatal streptozotocin-induced noninsulin-dependent diabetes mellitus in rats.
Hyean-Woo Lee (2003)
10.1210/JCEM.86.3.7304
Diabetic Dyslipidemia: Causes and Consequences
I. Goldberg (2001)
10.1023/A:1026498209874
Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles
M. van de Weert (2004)
10.1248/BPB.25.188
Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice.
K. Hayashi (2002)
10.1016/j.ajps.2018.03.003
Novel technique of insulin loading into porous carriers for oral delivery☆
Sarah Y. Eilleia (2018)
10.3390/md16060198
Anti-Obesity Effect of Chitosan Oligosaccharide Capsules (COSCs) in Obese Rats by Ameliorating Leptin Resistance and Adipogenesis
H. Pan (2018)
10.1089/jmf.2011.1882
Chitosan reduces plasma adipocytokines and lipid accumulation in liver and adipose tissues and ameliorates insulin resistance in diabetic rats.
Yu-Lin Hsieh (2012)
10.1080/17425247.2016.1178232
Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases
P. Rajitha (2016)
10.1016/J.IJPHARM.2004.05.007
Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
Shaoyun Yu (2004)
10.1016/J.JCONREL.2006.04.017
Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
M. George (2006)
10.1146/ANNUREV.PH.54.030192.004321
Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
S. Pilkis (1992)
10.1016/j.atherosclerosis.2015.01.039
New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
M. Taskinen (2015)
10.1016/S0378-5173(02)00486-6
Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
Yan Pan (2002)
10.3390/ijms140714214
Molecular Weight Dependent Glucose Lowering Effect of Low Molecular Weight Chitosan Oligosaccharide (GO2KA1) on Postprandial Blood Glucose Level in SD Rats Model
S. Jo (2013)
10.1161/01.CIR.101.9.975
Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.
S. Haffner (2000)
10.1016/0928-0987(95)00026-7
Chitosan as a nasal delivery system: evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models
T. Aspden (1996)
10.3390/md13053072
Antidiabetic Activity of Differently Regioselective Chitosan Sulfates in Alloxan-Induced Diabetic Rats
R. Xing (2015)
10.1039/c6nr00294c
In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy
F. Araújo (2016)
10.1152/ajpendo.90926.2008
Acyl-coenzyme A:cholesterol acyltransferases.
T. Chang (2009)
10.1007/s12072-018-9898-2
Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis
Roman Maslennikov (2018)
10.1002/jps.22823
Controlled delivery of basal level of insulin from chitosan-zinc-insulin-complex-loaded thermosensitive copolymer.
Mayura Oak (2012)
10.1007/12_2011_137
Chitosan and chitosan derivatives in drug delivery and tissue engineering
R. Riva (2011)
10.2337/DIABETES.52.1.124
Glucagon-Like Peptide 1 Induces Pancreatic β-Cell Proliferation Via Transactivation of the Epidermal Growth Factor Receptor
J. Buteau (2003)
10.1111/1753-0407.12161
Glucagon‐like peptide 1‐potentiated insulin secretion and proliferation of pancreatic β‐cells GLP‐1促进胰岛素分泌和胰岛β细胞增殖的机制
Xiaosong Ma (2014)
10.1016/S0140-6736(10)60484-9
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
N. Sarwar (2010)
10.1016/j.biomaterials.2013.07.021
Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT.
Er-Yuan Chuang (2013)
10.3390/md13127067
Long-Term Feeding of Chitosan Ameliorates Glucose and Lipid Metabolism in a High-Fructose-Diet-Impaired Rat Model of Glucose Tolerance
S. Liu (2015)
10.1515/jpem-2016-0111
The prevalence of dyslipidemia and associated factors in children and adolescents with type 1 diabetes
Tuba Bulut (2017)
10.3109/10408449209145322
A critical review of the toxicology of glutaraldehyde.
R. O. Beauchamp (1992)
10.1007/BF02209147
Structural basis for physiological regulation of paracellular pathways in intestinal epithelia
J. Madara (2005)
10.1016/S0378-5173(99)00030-7
Effect of chitosan on epithelial permeability and structure.
V. Dodane (1999)
10.1134/S000368381605015X
Analysis of toxicity and biocompatibility of chitosan derivatives with different physico-chemical properties
E. Svirshchevskaya (2016)
10.1016/j.fct.2007.12.012
A comparative study on hypoglycemic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats.
Hsien-Tsung Yao (2008)
10.1016/j.actbio.2015.12.017
Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin.
A. Verma (2016)
10.1016/j.biomaterials.2009.06.055
Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Lichen Yin (2009)
10.1007/s10924-016-0815-2
Chitosan Coated Cotton Fiber: Physical and Antimicrobial Properties for Apparel Use
M. A. Rahman Bhuiyan (2016)
10.1023/B:PHAR.0000026823.82950.ff
Nasal route and drug delivery systems
S. Türker (2004)
10.3390/md8071962
Chitosan Modification and Pharmaceutical/Biomedical Applications
J. Zhang (2010)
10.1016/j.nano.2009.04.007
Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method.
M. R. Avadi (2010)
10.1023/A:1018901302450
Chitosan as a Novel Nasal Delivery System for Peptide Drugs
L. Illum (2004)
10.1021/acs.jafc.5b00198
Supplementation of chitosan alleviates high-fat diet-enhanced lipogenesis in rats via adenosine monophosphate (AMP)-activated protein kinase activation and inhibition of lipogenesis-associated genes.
C. Chiu (2015)
10.1016/S0168-3659(99)00247-3
Nanosphere based oral insulin delivery.
G. Carino (2000)
10.1038/nrdp.2015.19
Type 2 diabetes mellitus
R. DeFronzo (2015)
10.1080/10717544.2018.1469685
Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids
Zhe Zhang (2018)
10.1016/J.BIOMATERIALS.2006.12.024
A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system.
J. Wu (2007)
10.1089/dia.2009.0180
Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.
C. Asche (2010)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar